Cargando…

Postprandial Glucose Spikes, an Important Contributor to Cardiovascular Disease in Diabetes?

Clinical trials investigating whether glucose lowering treatment reduces the risk of CVD in diabetes have thus far yielded mixed results. However, this doesn't rule out the possibility of hyperglycemia playing a major causal role in promoting CVD or elevating CVD risk. In fact, lowering glucose...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hanssen, Nordin M. J., Kraakman, Michael J., Flynn, Michelle C., Nagareddy, Prabhakara R., Schalkwijk, Casper G., Murphy, Andrew J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530333/ https://www.ncbi.nlm.nih.gov/pubmed/33195459 http://dx.doi.org/10.3389/fcvm.2020.570553

Ejemplares similares

Editorial: The role of inflammation, stem cells and progenitor cells in cardiovascular repair
por: Kawaguchi, Nanako, et al.
Publicado: (2023)

Neutrophil Migratory Patterns: Implications for Cardiovascular Disease
por: Dahdah, Albert, et al.
Publicado: (2022)

Acarbose for Postprandial Hypotension With Glucose Metabolism Disorders: A Systematic Review and Meta-Analysis
por: Wang, Biqing, et al.
Publicado: (2021)

Sex differences in contributors to coronary microvascular dysfunction
por: Kwan, Alan C., et al.
Publicado: (2023)

Targeting Postprandial Hyperglycemia With Physical Activity May Reduce Cardiovascular Disease Risk. But What Should We Do, and When Is the Right Time to Move?
por: Solomon, Thomas P. J., et al.
Publicado: (2018)

Mechanisms of Atherosclerosis Induced by Postprandial Lipemia
por: Zhao, Yixi, et al.
Publicado: (2021)

Cardiomyocyte Atrophy, an Underestimated Contributor in Doxorubicin-Induced Cardiotoxicity
por: Chen, De-Shu, et al.
Publicado: (2022)

Vascular biomarkers in the prevention of childhood cardiovascular risk: From concept to clinical implementation
por: Hanssen, Henner
Publicado: (2022)

Monocytes, Macrophages, and Metabolic Disease in Atherosclerosis
por: Flynn, Michelle C., et al.
Publicado: (2019)

Atrial fibrillation as a contributor to the mortality in patients with dementia: A nationwide cohort study
por: Chen, Yun-Yu, et al.
Publicado: (2023)

The accuracy of four formulas for LDL-C calculation at the fasting and postprandial states
por: Xu, Jin, et al.
Publicado: (2022)

Editorial: The importance of the central hemodynamic in the cardiovascular diseases development
por: Vilela-Martin, Jose Fernando, et al.
Publicado: (2022)

Glucose Control and Cardiovascular Disease: Is it important? No
por: Conget, Ignacio, et al.
Publicado: (2009)

Energy restriction and Roux-en-Y gastric bypass reduce postprandial α-dicarbonyl stress in obese women with type 2 diabetes
por: Maessen, Dionne E., et al.
Publicado: (2016)

Change in Postprandial Level of Remnant Cholesterol After a Daily Breakfast in Chinese Patients With Hypertension
por: Xu, Jin, et al.
Publicado: (2021)

Radiation-Induced Cardiovascular Disease: Mechanisms and Importance of Linear Energy Transfer
por: Sylvester, Christopher B., et al.
Publicado: (2018)

Immunological Insights into Cigarette Smoking-Induced Cardiovascular Disease Risk
por: Dahdah, Albert, et al.
Publicado: (2022)

Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: an observational analysis of the Nateglinide and Valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trial
por: Preiss, David, et al.
Publicado: (2012)

Potential Contributors to Increased Pulmonary Embolism Hospitalizations During the COVID-19 Pandemic: Insights From the German-Wide Helios Hospital Network
por: Husser, Daniela, et al.
Publicado: (2021)

Pulse wave analysis measurements: important, underestimated and undervalued parameters in cardiovascular health problems
por: Claessens, Philip Jan, et al.
Publicado: (2023)

Triglyceride-glucose index and estimated 10-year risk of a first hard cardiovascular event
por: Qu, Hua, et al.
Publicado: (2023)

Adults remember their birth weight, an important anamnestic item for cardiovascular and renal disease risk stratification
por: Crivelli-Meyer, Alexandra, et al.
Publicado: (2022)

Postload Plasma Glucose but Not Fasting Plasma Glucose Had a Greater Predictive Value for Cardiovascular Disease in a Large Prospective Cohort Study in Southwest China
por: Wang, Yingying, et al.
Publicado: (2022)

Origins and diversity of macrophages in health and disease
por: Sreejit, Gopalkrishna, et al.
Publicado: (2020)

Ideal cardiovascular health status and risk of cardiovascular disease and all-cause mortality: over a decade of follow-up in the Tehran lipid and glucose study
por: Hadaegh, Farzad, et al.
Publicado: (2022)

Triglyceride Glucose Index Is Associated With Arterial Stiffness and 10-Year Cardiovascular Disease Risk in a Chinese Population
por: Guo, Wen, et al.
Publicado: (2021)

Associations Between the Ankle-Brachial Index and Cardiovascular and All-Cause Mortality Are Similar in Individuals Without and With Type 2 Diabetes: Nineteen-year follow-up of a population-based cohort study
por: Hanssen, Nordin M.J., et al.
Publicado: (2012)

Circular RNAs and Cardiovascular Regeneration
por: Tang, Ling, et al.
Publicado: (2021)

Triglyceride-glucose (TyG) index is a predictor of arterial stiffness, incidence of diabetes, cardiovascular disease, and all-cause and cardiovascular mortality: A longitudinal two-cohort analysis
por: Muhammad, Iram Faqir, et al.
Publicado: (2023)

The Triglyceride-Glucose Index, an Insulin Resistance Marker, Was Non-linear Associated With All-Cause and Cardiovascular Mortality in the General Population
por: Liu, Xiao-cong, et al.
Publicado: (2021)

Glucose-Lowering and the Risk of Cardiovascular Events With Antidiabetic Therapies: A Systematic Review and Additive-Effects Network Meta-Analysis
por: de Carvalho, Luiz Sergio Fernandes, et al.
Publicado: (2022)

Arterial Stiffness in Patients With Renal Transplantation; Associations With Co-morbid Conditions, Evolution, and Prognostic Importance for Cardiovascular and Renal Outcomes
por: Korogiannou, Maria, et al.
Publicado: (2019)

Direct Cardiac Actions of Sodium-Glucose Cotransporter 2 Inhibition Improve Mitochondrial Function and Attenuate Oxidative Stress in Pressure Overload-Induced Heart Failure
por: Li, Xuan, et al.
Publicado: (2022)

Cardiovascular outcomes in patients treated with sodium-glucose transport protein 2 inhibitors, a network meta-analysis of randomized trials
por: Tornyos, Dániel, et al.
Publicado: (2022)

Response to Comment on: Hanssen et al. Associations Between the Ankle-Brachial Index and Cardiovascular and All-Cause Mortality Are Similar in Individuals Without and With Type 2 Diabetes: Nineteen-Year Follow-Up of a Population-Based Cohort Study. Diabetes Care 2012;35:1731–1735
por: Hanssen, Nordin M.J., et al.
Publicado: (2013)

Prognostic Significance of Triglyceride-Glucose Index for Adverse Cardiovascular Events in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis
por: Luo, Jin-Wen, et al.
Publicado: (2021)

Association of sodium-glucose cotransporter 2 inhibitors with cardiovascular outcome and safety events: A meta-analysis of randomized controlled clinical trials
por: Gong, Chen, et al.
Publicado: (2022)

Molecular and Integrative Physiological Effects of Isoflurane Anesthesia: The Paradigm of Cardiovascular Studies in Rodents using Magnetic Resonance Imaging
por: Constantinides, Christakis, et al.
Publicado: (2016)

Global cardiovascular risk assessment in the primary prevention of cardiovascular disease in adults: systematic review of systematic reviews
por: Collins, Dylan R J, et al.
Publicado: (2017)

Diverging effects of diabetes mellitus in patients with peripheral artery disease and abdominal aortic aneurysm and the role of advanced glycation end-products: ARTERY study — protocol for a multicentre cross-sectional study
por: de Vos, L C, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_agjpbq8p109cflar7c2tgqiu93